CN102417464A - 肾素抑制剂的替代合成方法及其中间体 - Google Patents

肾素抑制剂的替代合成方法及其中间体 Download PDF

Info

Publication number
CN102417464A
CN102417464A CN2011103045513A CN201110304551A CN102417464A CN 102417464 A CN102417464 A CN 102417464A CN 2011103045513 A CN2011103045513 A CN 2011103045513A CN 201110304551 A CN201110304551 A CN 201110304551A CN 102417464 A CN102417464 A CN 102417464A
Authority
CN
China
Prior art keywords
alkyl
aryl
carbonyl
alkoxy
alkoxyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011103045513A
Other languages
English (en)
Chinese (zh)
Inventor
G·塞德尔迈尔
S·J·迈克尔
H·鲁伊格尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN102417464A publication Critical patent/CN102417464A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126Acids containing more than four carbon atoms
    • C07C53/128Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
CN2011103045513A 2004-08-31 2005-08-30 肾素抑制剂的替代合成方法及其中间体 Pending CN102417464A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0419361.1 2004-08-31
GBGB0419361.1A GB0419361D0 (en) 2004-08-31 2004-08-31 Organic compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2005800292634A Division CN101010281B (zh) 2004-08-31 2005-08-30 肾素抑制剂的替代合成方法及其中间体

Publications (1)

Publication Number Publication Date
CN102417464A true CN102417464A (zh) 2012-04-18

Family

ID=33155811

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2011103045513A Pending CN102417464A (zh) 2004-08-31 2005-08-30 肾素抑制剂的替代合成方法及其中间体
CN2005800292634A Expired - Fee Related CN101010281B (zh) 2004-08-31 2005-08-30 肾素抑制剂的替代合成方法及其中间体

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2005800292634A Expired - Fee Related CN101010281B (zh) 2004-08-31 2005-08-30 肾素抑制剂的替代合成方法及其中间体

Country Status (17)

Country Link
US (2) US7910774B2 (enExample)
EP (2) EP1789377B1 (enExample)
JP (1) JP2008511573A (enExample)
KR (1) KR20070045300A (enExample)
CN (2) CN102417464A (enExample)
AT (1) ATE485257T1 (enExample)
AU (1) AU2005279351B2 (enExample)
BR (1) BRPI0514742A (enExample)
CA (1) CA2576749C (enExample)
DE (1) DE602005024282D1 (enExample)
ES (1) ES2354986T3 (enExample)
GB (1) GB0419361D0 (enExample)
MX (1) MX2007002419A (enExample)
PL (1) PL1789377T3 (enExample)
PT (1) PT1789377E (enExample)
RU (1) RU2411230C2 (enExample)
WO (1) WO2006024501A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0511686D0 (en) * 2005-06-08 2005-07-13 Novartis Ag Organic compounds
GB0519764D0 (en) 2005-09-28 2005-11-09 Novartis Ag Organic compounds
GB0521083D0 (en) 2005-10-17 2005-11-23 Novartis Ag Organic compounds
GB2431649A (en) * 2005-10-25 2007-05-02 Novartis Ag Alternative synthesis of aryl-octanoyl amide compounds
GB2431642A (en) * 2005-10-25 2007-05-02 Novartis Ag Alternative synthesis of aryl-octanoyl amide compounds
GB2431648A (en) * 2005-10-25 2007-05-02 Novartis Ag Alternative synthesis of aryl-octanoyl amide compounds
GB2431646A (en) * 2005-10-25 2007-05-02 Novartis Ag Alternative synthesis of aryl-octanoyl amide compounds
GB2431653A (en) * 2005-10-25 2007-05-02 Novartis Ag Alternative synthesis of aryl-octanoyl amide compounds
GB2431651A (en) * 2005-10-25 2007-05-02 Novartis Ag Synthesis of aryl-octanoyl amide compounds
GB0522789D0 (en) 2005-11-08 2005-12-14 Novartis Ag Organic compounds
CN101594857B (zh) 2006-11-07 2012-10-31 诺瓦提斯公司 阿利吉仑半富马酸盐的晶形
DE102007049039A1 (de) 2007-10-11 2009-04-16 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
SI2189442T1 (sl) 2008-11-20 2015-03-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek in intermediati za pripravo aliskirena
EP2464623B1 (en) * 2009-08-11 2020-11-04 Novartis AG The ring opening of lactones and lactams
US8203005B2 (en) 2009-10-29 2012-06-19 Carbo Design Llc Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren
CN101774986B (zh) * 2010-01-06 2012-03-28 浙江天宇药业股份有限公司 一种制备阿利克伦及其中间体的方法
CN102329244A (zh) * 2010-07-13 2012-01-25 凯瑞斯德生化(苏州)有限公司 一种rs-托特罗定的制备方法及中间体化合物
CN102372653A (zh) * 2010-08-10 2012-03-14 江苏恒瑞医药股份有限公司 二苯甲醇类衍生物、其制备方法及其在医药上的应用
EP2551260A1 (en) 2011-07-28 2013-01-30 Chemo Ibérica, S.A. Chemical process for opening ring compounds
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren
ITMI20120354A1 (it) * 2012-03-07 2013-09-08 Friulchem Spa Processo per la produzione di aliskirene
CN103044273B (zh) * 2012-11-29 2014-12-24 珠海保税区丽珠合成制药有限公司 一种酒石酸托特罗定的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88619A0 (en) * 1987-12-15 1989-07-31 Pfizer Non-peptidic renin inhibitors
DE3837197A1 (de) 1988-11-02 1990-05-03 Continental Ag Vorrichtung zum aufbereiten von unvulkanisiertem kautschuk
MY119161A (en) 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
GB9523493D0 (en) * 1995-11-16 1996-01-17 British Biotech Pharm Preparation of allyl succinate derivatives and starting materials therefore
PL212898B1 (pl) 2000-07-05 2012-12-31 Speedel Pharma Ag Sposób otrzymywania podstawionych amidów oktanoilowych oraz zwiazki posrednie wykorzystane w tym sposobie
AU2001273764A1 (en) * 2000-07-25 2002-02-05 Speedel Pharma Ag Process for the preparation of substituted octanoyl amides
ATE342887T1 (de) * 2000-12-14 2006-11-15 Speedel Pharma Ag Verfahren zur herstellung von aryloctanoyl-amiden
AU2003238007A1 (en) 2002-06-11 2003-12-22 Elan Pharmaceuticals, Inc. Methods of treating alzheimer's disease using aryl alkanoic acid amides

Also Published As

Publication number Publication date
ATE485257T1 (de) 2010-11-15
PT1789377E (pt) 2011-01-25
KR20070045300A (ko) 2007-05-02
BRPI0514742A (pt) 2008-06-24
PL1789377T3 (pl) 2011-04-29
CN101010281A (zh) 2007-08-01
MX2007002419A (es) 2007-04-23
US20110137044A1 (en) 2011-06-09
US8143416B2 (en) 2012-03-27
EP1789377B1 (en) 2010-10-20
US7910774B2 (en) 2011-03-22
JP2008511573A (ja) 2008-04-17
EP1789377A1 (en) 2007-05-30
EP1978012A1 (en) 2008-10-08
CA2576749C (en) 2012-10-16
CN101010281B (zh) 2011-12-21
AU2005279351B2 (en) 2009-04-23
RU2007111752A (ru) 2008-10-10
RU2411230C2 (ru) 2011-02-10
CA2576749A1 (en) 2006-03-09
US20070208055A1 (en) 2007-09-06
WO2006024501A1 (en) 2006-03-09
GB0419361D0 (en) 2004-10-06
DE602005024282D1 (de) 2010-12-02
AU2005279351A1 (en) 2006-03-09
ES2354986T3 (es) 2011-03-21

Similar Documents

Publication Publication Date Title
CN102417464A (zh) 肾素抑制剂的替代合成方法及其中间体
EP1082306A1 (en) Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
Avenoza et al. Enantioselective synthesis of (S)-and (R)-α-methylserines: application to the synthesis of (S)-and (R)-N-Boc-N, O-isopropylidene-α-methylserinals
EP2611776B1 (en) Production method of intermediate compound for synthesizing medicament
Toya et al. Stereocontrolled total synthesis and biological evaluation of (−)-and (+)-petrosin and its derivatives
CN104557583B (zh) 一种合成γ-氨基丁酸类手性化合物的方法
JP3479511B2 (ja) マトリックスメタロプロテイナーゼ阻害薬の製造に有用なヒンダードスルホンアミド類のアルキル化方法
Chavan et al. Divergent approach to the synthesis of (-)-balanol heterocycle and cis-3-hydroxypipecolic acid based on chiral 2-aminoalkanol equivalent
EP1931629B1 (en) Synthesis of renin inhibitors involving a cycloaddition reaction
CN1142223A (zh) N-取代的甘氨酸或甘氨酸酯的制备方法和用于靛蓝合成的用途
CN101081851B (zh) 一种α-氮杂螺环类药物模板的制备方法
JP2012116775A (ja) エクチナサイジンの製造方法
KR20090008725A (ko) 3-히드록시 피롤리딘 및 이의 유도체의 효율적 제조방법
WO2013061224A1 (en) Process for the preparation of aliskiren
Le Carrer-Le Goff et al. New organometallic approach to derivatives of α-substituted statines from N, N-dibenzylaminoaldehydes
JP3159518B2 (ja) アミノ置換スピロ化合物の製法
JP5344287B2 (ja) α−ジフルオロハロメチルカルボニル化合物の製造法
KR100684081B1 (ko) 광학 활성 3,4-디하이드로벤즈옥사진 유도체의 제조방법
EP1400511A1 (en) Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor
HK1150051A (en) Synthesis of renin inhibitors involving a cycloaddition reaction
CN101168514A (zh) 光学活性α-氨基辛二酸酯和α-氨基辛二酸单酯的实用合成方法
HK1184787B (en) Production method of intermediate compound for synthesizing medicament

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120418